Recent studies have associated CHRDL1 with various cancers, including breast cancer (21–24), lung cancer (25–28), gastric cancer (29, 30), thyroid cancer (31–34), T-cell acute lymphoblastic leukemia (T-ALL) (35), melanoma (36), and OSCC (37). Here, CHRDL1 is linked to thyroid gland carcinoma.